^^ shorted on Thus and was going to get back in when it dropped into $7.90's but decided to wait & glad i did
Looks like it is getting ready for another go at the chart breakout area - still positive graph despite this bit of consolidation.
This one has been knocking on the door to new territory for a while now - seems only a matter of time before it crashes through the resistance level on the chart?
latest news >> ImmunoGen Announces Investigational New Drug Application for IMGN632 for Hematological Malignancies is Active - https://finance.yahoo.com/news/immunogen-announces-investigational-drug-application-120000924.html
Looks to me as if it is going to challenge the $13 level again in the short term. Interesting that this latest news does not appear to have been leaked which is what we tend to see with larger more "mainstream" companies. Just shows, the lower down the food chain you go (the smaller the company) the less efficient markets are. Good research and confidence to see things through can still pay dividends.